Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dare Bioscience (DARE) Cash from Financing Activities (2016 - 2025)

Dare Bioscience's Cash from Financing Activities history spans 11 years, with the latest figure at $424129.0 for Q4 2025.

  • For Q4 2025, Cash from Financing Activities rose 300.7% year-over-year to $424129.0; the TTM value through Dec 2025 reached $19.3 million, up 5337.5%, while the annual FY2025 figure was $19.3 million, 5337.5% up from the prior year.
  • Cash from Financing Activities reached $424129.0 in Q4 2025 per DARE's latest filing, down from $18.7 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $35.2 million in Q3 2021 to a low of -$211320.0 in Q4 2024.
  • Average Cash from Financing Activities over 5 years is $5.9 million, with a median of $452195.0 recorded in 2023.
  • Peak YoY movement for Cash from Financing Activities: surged 530926900.0% in 2023, then tumbled 137.96% in 2025.
  • A 5-year view of Cash from Financing Activities shows it stood at $16.0 million in 2021, then crashed by 100.0% to -$1.0 in 2022, then soared by 530926900.0% to $5.3 million in 2023, then plummeted by 103.98% to -$211320.0 in 2024, then surged by 300.7% to $424129.0 in 2025.
  • Per Business Quant, the three most recent readings for DARE's Cash from Financing Activities are $424129.0 (Q4 2025), $18.7 million (Q3 2025), and -$43794.0 (Q2 2025).